Health Canada Approves Cysklar® (Cysteamine Ophthalmic Solution) 0.44% for Treatment of Corneal Crystals in People with Cystinosis
Leadiant Biosciences, Inc. today announced that Health Canada has approved Cysklar® (cysteamine ophthalmic solution) 0.44%, a topical eye drop solution indicated for the treatment of corneal cystine crystal accumulation in people with cystinosis.
